Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine

Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine

The objective of this review is to describe the evolution of lung tissue-derived diploid progenitor cell applications, ranging from historical biotechnological substrate functions for vaccine production and testing to current investigations around potential therapeutic use in respiratory tract regen...

Full description

Bibliographic Details
Main Authors: Alexis Laurent, Philippe Abdel-Sayed, Nathalie Hirt-Burri, Corinne Scaletta, Murielle Michetti, Anthony de Buys Roessingh, Wassim Raffoul, Lee Ann Applegate
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cells
Subjects:
active pharmaceutical ingredient
cell banking
cell therapy
COVID-19
diploid progenitor cells
inflammatory lung disease
Online Access:https://www.mdpi.com/2073-4409/10/10/2526

Internet

https://www.mdpi.com/2073-4409/10/10/2526

Similar Items